Please provide your email address to receive an email when new articles are posted on . The RhinAer system generates and applies 4 W of 60°C temperature-controlled bipolar radiofrequency energy to the ...
76% of participants achieved the responder rate (≥30% reduction in rTNSS). 91% achieved the minimum clinically important difference (MCID) of ≥1 point reduction in rTNSS. All 4 rTNSS subscores ...
For patients with allergic rhinitis whose symptoms aren't helped by one treatment, adding another may work, according to results of a systematic review and meta-analysis published in a recent issue of ...
Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment
GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced it has closed a $25 million Series B ...
An update of recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults, issued by members of the Joint Task Force on Practice Parameters (JTFPP), changes initial ...
Please provide your email address to receive an email when new articles are posted on . Temperature-controlled radiofrequency neurolysis of the posterior nasal nerve improved the symptom burden and ...
NEW ORLEANS -- Laser ablation of the posterior nasal nerve provided durable relief from rhinitis, and use of rhinitis medications decreased substantially, results of a small prospective series showed.
HOUSTON-(Aug. 4, 2022) – A new study at Houston Methodist evaluating the long-term effectiveness of a minimally invasive, in-office procedure could be a game changer for individuals with chronic ...
Considering taking supplements to treat perennial rhinitis? Below is a list of common natural remedies used to treat or reduce the symptoms of perennial rhinitis. Follow the links to read common uses, ...
Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment
GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced it has closed a $25 million Series B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results